Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novanta (NOVT) Asset Writedowns and Impairment: 2009-2024

Historic Asset Writedowns and Impairment for Novanta (NOVT) over the last 16 years, with Dec 2024 value amounting to $8.8 million.

  • Novanta's Asset Writedowns and Impairment fell 37.69% to $987,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 million, marking a year-over-year decrease of 49.90%. This contributed to the annual value of $8.8 million for FY2024, which is 17.25% up from last year.
  • Novanta's Asset Writedowns and Impairment amounted to $8.8 million in FY2024, which was up 17.25% from $7.5 million recorded in FY2023.
  • Over the past 5 years, Novanta's Asset Writedowns and Impairment peaked at $8.8 million during FY2024, and registered a low of $3.0 million during FY2022.
  • In the last 3 years, Novanta's Asset Writedowns and Impairment had a median value of $7.5 million in 2023 and averaged $6.4 million.
  • Its Asset Writedowns and Impairment has fluctuated over the past 5 years, first declined by 17.62% in 2022, then spiked by 150.70% in 2023.
  • Yearly analysis of 5 years shows Novanta's Asset Writedowns and Impairment stood at $4.0 million in 2020, then declined by 9.37% to $3.6 million in 2021, then decreased by 17.62% to $3.0 million in 2022, then surged by 150.70% to $7.5 million in 2023, then increased by 17.25% to $8.8 million in 2024.